The Food and Drug Administration said Pfizer’s coronavirus vaccine can be given to kids 12 to 15 years old — making it the first shot available for Americans younger than 16.
The timing of the agency’s decision means that many high-schoolers could be vaccinated by the time the next school year starts. Expanding vaccine eligibility to younger teens will also aid the Biden administration’s push to reach herd immunity.
Pfizer and its partner, BioNTech, said in late March that its vaccine was 100 percent effective in preventing Covid-19 in a trial of 2,300 U.S. kids ages 12 to 15, making it slightly more effective for that group than for adults. The companies are conducting a study of their vaccine in children from 6 months to 11 years old, and results are expected this summer. Pfizer has said it plans to apply in May for full U.S. approval of its vaccine for people 16 to 85.